Intracellular Financials
| ITCI Stock | USD 86.59 0.16 0.19% |
Intracellular |
Understanding current and past Intracellular Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intracellular's financial statements are interrelated, with each one affecting the others. For example, an increase in Intracellular's assets may result in an increase in income on the income statement.
Intracellular Stock Summary
Intracellular competes with Alkermes Plc, Ironwood Pharmaceuticals, Pacira BioSciences,, Collegium Pharmaceutical, and Neurocrine Biosciences. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US46116X1019 |
| CUSIP | 46116X101 |
| Location | New York; U.S.A |
| Business Address | 430 East 29th |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.intracellulartherapies.com |
| Phone | 646 440 9333 |
| Currency | USD - US Dollar |
Intracellular Key Financial Ratios
| Return On Equity | -0.099 | ||||
| Return On Asset | -0.0745 | ||||
| Target Price | 101.87 | ||||
| Number Of Employees | 610 | ||||
| Beta | 0.97 |
Intracellular Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intracellular's current stock value. Our valuation model uses many indicators to compare Intracellular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intracellular competition to find correlations between indicators driving Intracellular's intrinsic value. More Info.Intracellular Th is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intracellular's earnings, one of the primary drivers of an investment's value.Intracellular Th Systematic Risk
Intracellular's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Intracellular volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Intracellular Th correlated with the market. If Beta is less than 0 Intracellular generally moves in the opposite direction as compared to the market. If Intracellular Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Intracellular Th is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Intracellular is generally in the same direction as the market. If Beta > 1 Intracellular moves generally in the same direction as, but more than the movement of the benchmark.
About Intracellular Financials
What exactly are Intracellular Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Intracellular's income statement, its balance sheet, and the statement of cash flows. Potential Intracellular investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Intracellular investors may use each financial statement separately, they are all related. The changes in Intracellular's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intracellular's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Intracellular November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Intracellular help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intracellular Th. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intracellular Th based on widely used predictive technical indicators. In general, we focus on analyzing Intracellular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intracellular's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.59 | |||
| Information Ratio | 0.0762 | |||
| Maximum Drawdown | 16.17 | |||
| Value At Risk | (2.53) | |||
| Potential Upside | 3.04 |
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |